Collectively, PTH1R and CaSR represent opposing regulators in osteoarthritis: PTH1R exerts protective effects via bone-cartilage crosstalk, while CaSR drives pathological differentiation and matrix breakdown, highlighting their therapeutic potential as targets for osteoarthritis management. The gene discussed is CASR; the disease is osteoarthritis.